Loading company…
SomaLogic provides proteomics assays and technologies for healthcare and life sciences research.
Based in Boulder, US, SomaLogic provides proteomics assays and technology, including the SomaScan platform for measuring 11,000 proteins from a 55-µL sample. Its services support academic medical centers and pharmaceutical companies in health and disease research. Illumina acquired the company in June 2025 for USD 350 million in cash.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in